The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Anesthesia and Analgesia

• Publication date

  2008-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1213/ane.0b013e31817300bePMID 18499626PMCID PMC2443862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Endomorphin System and Its Evolving Neurophysiological Role

  2007cited by this paper
• Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids.

  2006cited by this paper
• [35S]GTPγS binding stimulated by endomorphin-2 and morphiceptin analogs

  2006cited by this paper
• Inhibition by endomorphin-1 and endomorphin-2 of excitatory transmission in adult rat substantia gelatinosa neurons.

  2006cited by this paper
• [(35)S]GTPgammaS binding stimulated by endomorphin-2 and morphiceptin analogs.

  2006cited by this paper
• Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.

  2006cited by this paper
• Endogenous opioids upregulate brain‐derived neurotrophic factor mRNA through δ‐ and µ‐opioid receptors independent of antidepressant‐like effects

  2006cited by this paper
• The Role of Intrathecal Drugs in the Treatment of Acute Pain

  2005cited by this paper
• The role of central mu opioid receptors in opioid-induced itch in primates.

  2004cited by this paper
• Evidence for Development of Capillary Leak Syndrome Associated with Cardiopulmonary Bypass in Pediatric Patients with the Homozygous C4A Null Phenotype

  2004cited by this paper
• Antiallodynic Effects of Systemic and Intrathecal Morphine in the Spared Nerve Injury Model of Neuropathic Pain in Rats

  2004cited by this paper
• Studies of μ-, κ-, and δ-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys

  2003cited by this paper
• Degradation of endomorphin-2 at the supraspinal level in mice is initiated by dipeptidyl peptidase IV: an in vitro and in vivo study.

  2003cited by this paper
• Characterization of scratching responses in rats following centrally administered morphine or bombesin

  2003cited by this paper
• Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.

  2003cited by this paper
• Clinical Pharmacology of Opioids for Pain

  2002cited by this paper
• In vitro quantitative study of the degradation of endomorphins.

  2002cited by this paper
• Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.

  2001cited by this paper
• Pharmacology of amphibian opiate peptides.

  2000cited by this paper
• Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.

  2000cited by this paper
• Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists.

  2000cited by this paper
• Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice.

  2000cited by this paper
• Evidence-based review of the literature on intrathecal delivery of pain medication.

  2000cited by this paper
• Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse.

  2000cited by this paper
• Lesions of the dorsolateral funiculus block supraspinal opioid delta receptor mediated antinociception in the rat.

  1999cited by this paper
• Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats.

  1999cited by this paper
• Intrathecal drug therapy for chronic pain: from basic science to clinical practice.

  1999cited by this paper
• Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor.

  1999cited by this paper
• Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats.

  1999cited by this paper
• Endomorphin‐Stimulated [35S]GTPγS Binding in Rat Brain: Evidence for Partial Agonist Activity at μ‐Opioid Receptors

  1998influential reference
• Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.

  1998cited by this paper
• Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.

  1998cited by this paper
• In vivo apparent affinity and efficacy estimates for μ opiates in a rat tail-withdrawal assay

  1998cited by this paper
• Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord.

  1998cited by this paper
• Itch-associated response and antinociception induced by intracisternal endomorphins in mice.

  1998cited by this paper
• Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.

  1998cited by this paper
• Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.

  1998cited by this paper
• Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists

  1998cited by this paper
• mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.

  1997cited by this paper
• Spinal analgesic actions of the new endogenous opioid peptides endomorphin‐1 and ‐2

  1997cited by this paper
• Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex.

  1997cited by this paper
• A potent and selective endogenous agonist for the µ-opiate receptor

  1997cited by this paper
• A potent and selective endogenous agonist for the mu-opiate receptor.

  1997cited by this paper
• Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

  1996cited by this paper
• Differential right shifts in the dose‐response curve for intrathecal morphine and sufentanil as a function of stimulus intensity

  1995cited by this paper
• Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy.

  1993cited by this paper
• A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.

  1993cited by this paper
• Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists

  1992cited by this paper
• Opioid receptors and endogenous opioid peptides

  1991cited by this paper
• Spinal antinociceptive actions of μ‐ and κ‐opioids: the importance of stimulus intensity in determining ‘selectivity’ between reflexes to different modalities of noxious stimulus

  1989cited by this paper
• Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.

  1988cited by this paper

• The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

  2022cites this paper
• Sialorphin Potentiates Effects of [Met5]Enkephalin without Toxicity by Action other than Peptidase Inhibition

  2020cites this paper
• Preemptive intrathecal administration of endomorphins relieves inflammatory pain in male mice via inhibition of p38 MAPK signaling and regulation of inflammatory cytokines

  2018cites this paper
• Effect of Peptidase Inhibitors on Dynorphin A (1-17) or (1-13)-Induced Antinociception and Toxicity at Spinal Level

  2017cites this paper
• Estrogens synthesized and acting within a spinal oligomer suppress spinal endomorphin 2 antinociception: ebb and flow over the rat reproductive cycle

  2017cites this paper
• Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics

  2017cites this paper
• Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1–17) or (1–13) in the rat

  2015cites this paper
• Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats

  2015cites this paper
• Antinociceptive effects of endomorphin-2: suppression of substance P release in the inflammatory pain model rat.

  2015cites this paper
• Potentiation of [Met5]enkephalin-induced antinociception by mixture of three peptidase inhibitors in rat

  2014cites this paper
• Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine.

  2013cites this paper
• Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists

  2013cites this paper
• Endomorphin-2: A Biased Agonist at the μ-Opioid Receptor

  2012cites this paper
• Efficient chemo-enzymatic synthesis of endomorphin-1 using organic solvent stable proteases to green the synthesis of the peptide

  2011cites this paper
• Dipeptidyl peptidase III: a multifaceted oligopeptide N‐end cutter

  2011cites this paper
• Metodología de trabajo para la actualización del Programa Formativo de la especialidad de Anestesiología y Reanimación. Una propuesta desde la Sección de Docencia y Formación de la Sociedad Española de Anestesiología y Reanimación

  2010cites this paper
• Origins of endomorphin-2 immunopositive fibers and terminals in the spinal dorsal horn of the rat.

  2010cites this paper
• Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

  2009cites this paper
• Endogenous opiates and behavior: 2008.

  2009cites this paper
• Pharmacological Studies of NOP Receptor Agonists as Novel Analgesics

  2009cites this paper